M

Medpace Holdings
D

MEDP

300.85
USD
2.49
(0.83%)
مغلق
حجم التداول
25,011
الربح لكل سهم
12
العائد الربحي
-
P/E
23
حجم السوق
8,646,913,068
أصول ذات صلة
DXCM
DXCM
1.120
(1.37%)
83.080 USD
HOLX
HOLX
0.450
(0.70%)
65.200 USD
O
OMCL
0.000
(0.00%)
29.220 USD
PODD
PODD
1.98
(0.65%)
306.56 USD
RMD
RMD
2.200
(0.88%)
251.660 USD
T
TDOC
0.17500
(2.55%)
7.03000 USD
WST
WST
2.620
(1.18%)
224.430 USD
المزيد
الأخبار المقالات

العنوان: Medpace Holdings

القطاع: Healthcare
الصناعة: Diagnostics & Research
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.